Artivion: JMP Securities Raises PT to $42 from $33, Maintains Market Outperform

Artivion: JMP Securities Raises PT to $42 from $33, Maintains Market Outperform

JMP Securities has increased its price target for Artivion Inc. (NYSE:AORT) from $33 to $42, maintaining a Market Outperform rating. The upgrade comes on the heels of the company's strong second-quarter 2025 results, which exceeded analyst expectations by approximately $5 million, representing a 5% beat. This performance was driven by continued progress in Artivion’s AMDS stent graft launch and the On-X heart valve business, which grew 22% and 24% year-over-year, respectively [3].

Artivion reported a quarterly revenue of $113M, surpassing the consensus estimate of $107.84M. The company also raised its full-year sales guidance, projecting growth of 12-14% year-over-year in constant currency terms. The strong performance has been recognized by other analysts as well; Stifel has increased its price target to $36, maintaining a Buy rating, while Citizens JMP reiterated its Market Outperform rating with a $33 price target [3].

The company’s robust financial health, as indicated by a current ratio of 5.53 and an overall Financial Health score rated as "GOOD" by InvestingPro, further supports the bullish outlook. Additionally, Artivion shareholders approved executive compensation and the selection of Ernst & Young LLP as the independent auditor for the fiscal year 2025, and the company is engaging in a private deal to repurchase $95 million in convertible notes [3].

Investors should take note of these developments, as they underscore Artivion's strategic focus on financial and operational growth. However, it is essential to remain vigilant to potential risks, such as investment risk, as identified by Simply Wall St [1].

References:
[1] https://simplywall.st/stocks/us/healthcare/nyse-aort/artivion/news/artivions-nyseaort-growing-losses-dont-faze-investors-as-the
[2] https://in.investing.com/news/earnings/artivion-earnings-beat-by-024-revenue-topped-estimates-4951610
[3] https://ng.investing.com/news/analyst-ratings/artivion-stock-price-target-raised-to-42-from-33-at-jmp-on-strong-growth-93CH-2051975